Optibrium receives further investment from Kester Capital

Optibrium receives further investment from Kester Capital   Second round of funding from existing investors will further drive company expansion and commercial growth of its AI-enabled drug discovery technology. CAMBRIDGE, UK, 21 June 2022 – Optibrium™, a developer of...

Optimising Operations & Processes in Biotech Labs

Optimising Operations & Processes in Biotech Labs Recent developments in computational tools and how these can solve operational challenges in biotech labs. Interview published by Lab Manager: – Biotechnology labs face many challenges, such as operations and...
Inspyra

Inspyra

Inspyra This worked example uses Inspyra™ to interactively explore optimisation strategies to achieve a selective inhibitor of DPP-4 with appropriate physicochemical properties. Starting from a data set of compounds representing three chemical series based on...
Inspyra Matched Series Analysis

Inspyra Matched Series Analysis

Inspyra Matched Series Analysis In this worked example, we will explore ways to use the Inspyra Panel, in combination with Matched Series Analysis (MSA). MSA goes beyond Matched Pair Analysis and uses longer series of matched compounds to propose new substitutions...